Rakovina Therapeutics Inc (TSE:RKV) has launched an replace.
Rakovina Therapeutics Inc. has efficiently accomplished an oversubscribed non-public placement, elevating $2 million to advance its...
Affected person specimensHuman LUAD most cancers and adjoining non-tumor tissue samples for RT-qPCR evaluation have been obtained from a complete of 112 sufferers...